These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
714 related items for PubMed ID: 19064624
1. A trial of combination antimalarial therapies in children from Papua New Guinea. Karunajeewa HA, Mueller I, Senn M, Lin E, Law I, Gomorrai PS, Oa O, Griffin S, Kotab K, Suano P, Tarongka N, Ura A, Lautu D, Page-Sharp M, Wong R, Salman S, Siba P, Ilett KF, Davis TM. N Engl J Med; 2008 Dec 11; 359(24):2545-57. PubMed ID: 19064624 [Abstract] [Full Text] [Related]
5. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic. Mayxay M, Khanthavong M, Lindegårdh N, Keola S, Barends M, Pongvongsa T, Yapom R, Annerberg A, Phompida S, Phetsouvanh R, White NJ, Newton PN. Clin Infect Dis; 2004 Oct 15; 39(8):1139-47. PubMed ID: 15486837 [Abstract] [Full Text] [Related]
6. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial. West African Network for Clinical Trials of Antimalarial Drugs (WANECAM). Lancet; 2018 Apr 07; 391(10128):1378-1390. PubMed ID: 29606364 [Abstract] [Full Text] [Related]
7. Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria. Gogtay N, Kannan S, Thatte UM, Olliaro PL, Sinclair D. Cochrane Database Syst Rev; 2013 Oct 25; 2013(10):CD008492. PubMed ID: 24163021 [Abstract] [Full Text] [Related]
9. Azithromycin for treating uncomplicated malaria. van Eijk AM, Terlouw DJ. Cochrane Database Syst Rev; 2011 Feb 16; 2011(2):CD006688. PubMed ID: 21328286 [Abstract] [Full Text] [Related]
10. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua New Guinea. Tavul L, Hetzel MW, Teliki A, Walsh D, Kiniboro B, Rare L, Pulford J, Siba PM, Karl S, Makita L, Robinson L, Kattenberg JH, Laman M, Oswyn G, Mueller I. Malar J; 2018 Oct 05; 17(1):350. PubMed ID: 30290825 [Abstract] [Full Text] [Related]
13. Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial. van der Pluijm RW, Tripura R, Hoglund RM, Pyae Phyo A, Lek D, Ul Islam A, Anvikar AR, Satpathi P, Satpathi S, Behera PK, Tripura A, Baidya S, Onyamboko M, Chau NH, Sovann Y, Suon S, Sreng S, Mao S, Oun S, Yen S, Amaratunga C, Chutasmit K, Saelow C, Runcharern R, Kaewmok W, Hoa NT, Thanh NV, Hanboonkunupakarn B, Callery JJ, Mohanty AK, Heaton J, Thant M, Gantait K, Ghosh T, Amato R, Pearson RD, Jacob CG, Gonçalves S, Mukaka M, Waithira N, Woodrow CJ, Grobusch MP, van Vugt M, Fairhurst RM, Cheah PY, Peto TJ, von Seidlein L, Dhorda M, Maude RJ, Winterberg M, Thuy-Nhien NT, Kwiatkowski DP, Imwong M, Jittamala P, Lin K, Hlaing TM, Chotivanich K, Huy R, Fanello C, Ashley E, Mayxay M, Newton PN, Hien TT, Valecha N, Smithuis F, Pukrittayakamee S, Faiz A, Miotto O, Tarning J, Day NPJ, White NJ, Dondorp AM, Tracking Resistance to Artemisinin Collaboration. Lancet; 2020 Apr 25; 395(10233):1345-1360. PubMed ID: 32171078 [Abstract] [Full Text] [Related]
14. High efficacy of artemether-lumefantrine and declining efficacy of artesunate + sulfadoxine-pyrimethamine against Plasmodium falciparum in Sudan (2010-2015): evidence from in vivo and molecular marker studies. Adeel AA, Elnour FA, Elmardi KA, Abd-Elmajid MB, Elhelo MM, Ali MS, Adam MA, Atta H, Zamani G, Warsame M, Barrette A, Mohammady HE, Nada RA. Malar J; 2016 May 21; 15(1):285. PubMed ID: 27209063 [Abstract] [Full Text] [Related]
15. Four Artemisinin-Based Treatments in African Pregnant Women with Malaria. PREGACT Study Group, Pekyi D, Ampromfi AA, Tinto H, Traoré-Coulibaly M, Tahita MC, Valéa I, Mwapasa V, Kalilani-Phiri L, Kalanda G, Madanitsa M, Ravinetto R, Mutabingwa T, Gbekor P, Tagbor H, Antwi G, Menten J, De Crop M, Claeys Y, Schurmans C, Van Overmeir C, Thriemer K, Van Geertruyden JP, D'Alessandro U, Nambozi M, Mulenga M, Hachizovu S, Kabuya JB, Mulenga J. N Engl J Med; 2016 Mar 10; 374(10):913-27. PubMed ID: 26962727 [Abstract] [Full Text] [Related]
19. Therapeutic efficacies of artesunate-sulfadoxine-pyrimethamine and chloroquine-sulfadoxine-pyrimethamine in vivax malaria pilot studies: relationship to Plasmodium vivax dhfr mutations. Tjitra E, Baker J, Suprianto S, Cheng Q, Anstey NM. Antimicrob Agents Chemother; 2002 Dec 10; 46(12):3947-53. PubMed ID: 12435700 [Abstract] [Full Text] [Related]
20. Artemisinin-naphthoquine versus artemether-lumefantrine for uncomplicated malaria in Papua New Guinean children: an open-label randomized trial. Laman M, Moore BR, Benjamin JM, Yadi G, Bona C, Warrel J, Kattenberg JH, Koleala T, Manning L, Kasian B, Robinson LJ, Sambale N, Lorry L, Karl S, Davis WA, Rosanas-Urgell A, Mueller I, Siba PM, Betuela I, Davis TM. PLoS Med; 2014 Dec 10; 11(12):e1001773. PubMed ID: 25549086 [Abstract] [Full Text] [Related] Page: [Next] [New Search]